MedTrace Logo

High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection

NCT03042273 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-03-18

No results posted yet for this study

Summary

This clinical trial is a Phase 2, multicenter, placebo-controlled, double-blind, parallel-arm study to evaluate the efficacy and safety of High Strength Cranberry (500mg Pacran®) in preventing UTI (cystitis) in women with a history of recurrent UTI (rUTI).

Conditions

Interventions

DIETARY_SUPPLEMENT

High Strength Cranberry

Softgel capsule

DIETARY_SUPPLEMENT

Placebo

Soy oil to match High Strength Cranberry Softgel Capsule

Sponsors & Collaborators

  • Commonwealth Scientific and Industrial Research Organisation, Australia

    collaborator OTHER_GOV

  • Swisse Wellness Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Welma Stonehouse, PhD · Commonwealth Scientific and Industrial Research Organisation, Australia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03042273 on ClinicalTrials.gov